A study has revealed that people aged between 18-39, who have had the second dose of the Moderna vaccine, have suffered from more cases of myocarditis than compared to those who have received the Pfizer vaccine.
A study has revealed that people aged between 18-39, who have had the second dose of the Moderna vaccine, have suffered from more cases of myocarditis than compared to those who have received the Pfizer vaccine.